Krystal Biotech Inc (KRYS)
Interest coverage
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 12,897 | -139,975 | -68,078 | -32,167 | -22,081 |
| Interest expense | US$ in thousands | 0 | 0 | 1,492 | 0 | — |
| Interest coverage | — | — | -45.63 | — | — |
December 31, 2023 calculation
Interest coverage = EBIT ÷ Interest expense
= $12,897K ÷ $0K
= —
Based on the data provided, it appears that Krystal Biotech Inc did not report any specific interest coverage ratios for the years ending December 31, 2023, 2022, and 2020. However, the interest coverage ratio for the year ending December 31, 2021, was -45.63.
The negative interest coverage ratio of -45.63 for 2021 indicates that Krystal Biotech Inc's operating income was not sufficient to cover its interest expenses during that period. A negative interest coverage ratio suggests that the company may have faced challenges meeting its interest obligations with its operating income.
It is important to note that the absence of data for certain years may limit the ability to assess the trend of interest coverage over time. Additionally, further analysis and additional financial information would be needed to fully understand the financial health and performance of Krystal Biotech Inc in relation to its interest obligations.
Peer comparison
Dec 31, 2023